At the Euretina congress, Prof. John Marshall, who developed the clinical use of 2RT laser in macular degeneration, presented the results of a clinical trial whose purpose is to determine whether 2RT nanosecond laser therapy slows the progression to advanced age-related macular degeneration. According to the researcher, the study shows that the treatment can slow the progression of the disease up to 4 times.
At the Euretina congress, Prof. John Marshall, who developed the clinical use of 2RT laser in macular degeneration, presented the results of a clinical trial whose purpose is to determine whether 2RT nanosecond laser therapy slows the progression to advanced age-related macular degeneration. According to the researcher, the study shows that the treatment can slow the progression of the disease up to 4 times.
VIENNA 2018: EURETINA - EUCORNEA - ESCRS
The physics of Internal and External Tamponade
Scientific work on Endotamponades by Professor Wong
Macular degeneration: retina rejuvenation with the 2RT laser
Diabetic Macular Edema: now treatment can be customized
Edema maculare diabetico: ora possibile personalizzare la cura
A study on the lens regenerating potential of stem cells
Refractive enhancement using Lasik techniques
Diabetic Macular Edema: careful patient management
Incoming cataract treatment strategies
Steroid use in treating Macular Edema
The management of cataract surgery in Diabetic Macul. Edema
Indications for vitrectomy in diabetic retinopathy
The surgical treatment of Macular Edema
Wet macular degeneration: 2 studies on Aflibercept
